drugset / Trial / NCT04268927
Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The object of this study is to evaluate the efficacy of extended letrozole co-treatment with GnRH-antagonist protocol in ovarian stimulation of poor responder patients undergoing IVF-ET.
Timeline
- Start
- 2018-04-01
- Primary completion
- 2020-03-20
- Completion
- 2020-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 2.5 mg | — |
| Comparator | Bravelle | Unknown | 300 iu | — |
| Comparator | Cetrorelix | Other / unclassified | 0.25 mg | Subcutaneous |